Hi-Tech Pharmacal Reports Q2 EPS of $.76

Hi-Tech Pharmacal Co., Inc. HITK today reported results for the quarter ended October 31, 2010. For the three months ended October 31, 2010, the Company reported net sales of $44.9 million, an increase of 10% from $40.9 million for the same period last year. Net income for the three month period was $10.0 million as compared to $7.4 million in the prior period. This resulted in diluted earnings per share of $0.76 compared to $0.60 per share in the prior year.